Our results demonstrate that GC potentiates CMA activity in macrophages, leading to promoted degradation of the NLRP3 inflammasome, suppression of NLRP3/IL-1β-mediated inflammation, and ultimately conferring protection against atherosclerosis. The gene discussed is NLRP3; the disease is atherosclerosis.